KLISBio Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Employees
  • 16

Employees
  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 7

KLISBio General Information

Description

Developer of an innovative medical technology designed to find new ways for tissue regeneration. The company's technology offers silk-based bio-materials that help to regenerate human tissues, including those present in the vascular system, and then to degrade and be safely absorbed in the body, enabling medical research companies to avail premium products harnessing the power of nano-fibers and use them for the treatment of tissue-related diseases.

Contact Information

Website
www.klis.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Primary Office
  • Via Cavour 2
  • 22074 Lomazzo(Como)
  • Italy

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

KLISBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 00.000 Completed Generating Revenue
5. Early Stage VC (Series A) 21-Apr-2016 00.000 00.000 Completed Generating Revenue
4. Seed Round 11-Dec-2015 00000 00000 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Grant 05-Aug-2015 $55K Completed Generating Revenue
1. Grant 05-Dec-2014 $31.1K Completed Startup
To view KLISBio’s complete valuation and funding history, request access »

KLISBio Patents

KLISBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2018248085-A1 Nanofibers comprising fibroin as well as system comprising hydrogel and said nanofibers Pending 04-Apr-2017 000000000
CA-3058866-A1 Nanofibers comprising fibroin as well as system comprising hydrogel and said nanofibers Pending 04-Apr-2017 000000000
EP-3607117-A1 Nanofibers comprising fibroin as well as system comprising hydrogel and said nanofibers Pending 04-Apr-2017 000000000
US-20200109491-A1 Nanofibers comprising fibroin as well as system comprising hydrogel and said nanofibers Pending 04-Apr-2017 000000000 0
US-20170312387-A1 Process for the production of a hybrid structure consisting of coupled silk fibroin microfibers and nanofibers, hybrid structure thus obtained and its use as implantable medical device Active 27-Oct-2014 A61L27/227 0
To view KLISBio’s complete patent history, request access »

KLISBio Executive Team (6)

Name Title Board Seat Contact Info
Gabriele Grecchi Co-Founder, Chief Executive Officer & Board Member
Rodrigo Bianchi President & Chairman
Jason Schense Ph.D Chief Business Officer & Chief Operating Officer
Antonio Alessandrino Ph.D Co-Founder, Chief Technology Officer & Board Member
Giuliano Freddi Ph.D Co-Founder & Chief Scientific Officer
You’re viewing 5 of 6 executive team members. Get the full list »

KLISBio Board Members (4)

Name Representing Role Since
Antonio Alessandrino Ph.D KLISBio Co-Founder, Chief Technology Officer & Board Member 000 0000
Gabriele Grecchi KLISBio Co-Founder, Chief Executive Officer & Board Member 000 0000
Rodrigo Bianchi KLISBio President & Chairman 000 0000
You’re viewing 3 of 4 board members. Get the full list »

KLISBio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

KLISBio Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Xyence Venture Capital Minority 000 0000 000000 0
Horizon 2020 SME Instrument Government 000 0000 000000 0
PNICube Corporation 000 0000 000000 0
Anya Capital Venture Capital Minority 000 0000 000000 0
ComoNext Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »